WASHINGTON, D.C. (AP) - The U.S. National Institutes of Health will collaborate with numerous biopharmaceutical companies and disease foundations on an unusual project to find and bring new medicines to patients faster.
The Accelerating Medicines Partnership, just announced, will focus on the early part of drug research - identifying biological targets present in a disease, such as abnormal genes or particular proteins.
The partnership will aim to develop new diagnostic tests and therapies focused on those targets, but more quickly and at a lower cost than today's typical drug development.
The new collaboration will start with pilot projects in three disease areas: Alzheimer's, type 2 diabetes and autoimmune disorders such as rheumatoid arthritis and lupus.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.